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Abstract
Background: Diabetes is a serious chronic metabolic disorder. Trichosanthes kirilowii Maxim. (TK) is traditionally used
for the treatment of diabetes in traditional Chinese medicine (TCM). However, the clinical application of TK on diabetic
patients and the hypoglycemic efficacies of TK are still unclear.
Methods: A retrospective cohort study was conducted to analyze the usage of Chinese herbs in patients with type 2
diabetes in Taiwan. Glucose tolerance test was performed to analyze the hypoglycemic effect of TK. Proteomic approach
was performed to identify the protein constituents of TK. Insulin receptor (IR) kinase activity assay and glucose tolerance
tests in diabetic mice were further used to elucidate the hypoglycemic mechanisms and efficacies of TK.
Results: By a retrospective cohort study, we found that TK was the most frequently used Chinese medicinal herb in type
2 diabetic patients in Taiwan. Oral administration of aqueous extract of TK displayed hypoglycemic effects in
a dose-dependent manner in mice. An abundant novel TK protein (TKP) was further identified by proteomic approach.
TKP interacted with IR by docking analysis and activated the kinase activity of IR. In addition, TKP enhanced the
clearance of glucose in diabetic mice in a dose-dependent manner.
Conclusions: In conclusion, this study applied a bed-to-bench approach to elucidate the hypoglycemic efficacies and
mechanisms of TK on clinical usage. In addition, we newly identified a hypoglycemic protein TKP from TK. Our findings
might provide a reasonable explanation of TK on the treatment of diabetes in TCM.
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Background
Diabetes mellitus is a commonly metabolic syndrome
that occurs because either the beta islet of pancreas does
not produce enough insulin or the body cannot effect-
ively utilize insulin [1, 2]. The prevalence of diabetes
continues to grow, with diagnosed diabetes now reach-
ing 415 million worldwide. About 2.5 to 15% of medical
expenditures in many countries are attributed to
diabetes [3]. There are many drugs currently used in the
treatment of diabetes. However, some reports indicate
that treatment with synthetic drugs is responsible for
various adverse effects, such as hypoglycemia and
gastrointestinal problems [4]. Therefore, the approach of
better agents from traditional Chinese medicine (TCM)
or natural products has been gaining a significant
importance now, even in coming years [5].
TCM has been practiced for thousands of years in
China and the Far East, and plays a major role in the
health care [5–7]. Since ancient times, several Chinese
herbal formulae as well as Chinese medicinal herbs have
been commonly used in patients with Xiao Ke (消渴), a
diabetic condition characterized by persistent thirst and
hunger, copious urination, and weight loss. For example,
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Chu-Yeh-Shih-Kao-Tang (CYSKT) is a TCM formula
that is composed of bamboo leaves, gypsum, pinellia rhi-
zome, ginseng root, licorice root, rice, and ophiopogon
tuber. It is traditionally used for the treatment of re-
spiratory diseases and diabetes in China. Our previous
study indicated that CYSKT significantly reduces
glycated hemoglobin A1c values in diabetic patients in
Taiwan. It also reduces fasting blood glucose levels and
stimulates blood glucose clearance in diabetic mice via
affecting insulin signaling pathway [8]. Danzhi Jiangtang
Capsule, a Chinese medicinal formula consisting of
cortex moutan, heterophylly falsestarwort root, unpro-
cessed rehmannia root, oriental waterplantain rhizome,
dodder seed and leech, has been used for treatment of
diabetes for many years. Recent study showed that
Danzhi Jiangtang Capsule attenuates streptozotocin
(STZ)-induced type 1 diabetes in rats via the suppression
of pancreatic beta cell apoptosis [9].
Trichosanthes kirilowii Maxim. (TK) is a member of
family Cucurbitaceae. Trichosanthes root, also named as
gualou or Tian-Hua Fen, is firstly described in Tujing
Bencao (Illustrated Classics of Materia Medica) 950 year
ago. It is traditionally used for the treatment of diabetes
and its complications in China, Taiwan, and Eastern Asia
[10, 11]. Previous study indicated that trichosanthes root
and its glycan constituents exhibit hypoglycemic activ-
ities in normal or alloxan-induced hyperglycemic mice
[12]. Lectins from TK also display hypoglycemic effects
in alloxan-induced diabetic mice and stimulate the
incorporation of D-[3H]glucose into lipids in isolated rat
epididymal adipocytes [13, 14]. However, the clinical
application of trichosanthes root on diabetic patients,
and the hypoglycemic mechanisms of TK and its constit-
uents are still unclear. To address these questions, we
applied a bed-to-bench approach by surveying the usage
of TK in clinics and analyzing the glucose clearance abil-
ities of TK in mice. Two-dimensional electrophoresis
(2-DE) coupled with liquid chromatography and tandem
mass spectrometry (LC-MS/MS) was applied to identify
the protein constituents of TK. Insulin receptor (IR)
kinase activity assay and glucose tolerance tests in
diabetic mice were further used to elucidate the
hypoglycemic mechanisms and efficacies of TK.
Methods
Prescription pattern of TCM on diabetic patients in
National Health Insurance system
A retrospective study was conducted using registration
and claim datasets of the year 2002 from National
Health Insurance Research Database (NHIRD), which
covers claims of ambulatory care, inpatient services,
dental services, and prescriptions from 99% of the over-
all population in Taiwan. The observed patients were
identified from NHIRD by a principal diagnosis of
diabetes (International Classification of Diseases, Nine
Revision, Clinical Modification ICD-9-CM, 250 and
250.0). There were 774,367 patients diagnosed as type 2
diabetes in 2002. All patients with type 2 diabetes and
TCM treatments were included. Patients’ records/infor-
mation were anonymized and de-identified prior to ana-
lysis. This study was approved by Ethics Review Board of
Chinese Medical University Hospital (Permit No.
DMR97-IRB-272).
Observation of TK usage in Longitudinal Health Insurance
Database 2000 (LHID 2000)
LHID 2000 contains one million enrollees of all the
original NHIRD, which was randomly sampled from
Registry for Beneficiaries of the NHIRD during the
period of 1996–2008. There are approximately 23.75
million individuals in this registry. The usage of TK in
patients with endocrine, nutritional and metabolic dis-
eases, and immunity disorders (ICD-9-CM, 240–279) in
LHID 2000 was conducted a retrospective cohort study.
Preparation of aqueous extract of TK (TKE)
Roots of TK were purchased from Sun-Ten Pharmaceut-
ical Company (Taipei, Taiwan). The voucher specimens
have been deposited in the Graduate Institute of Chinese
Medicine, China Medical University. Trichosanthes
roots were ground to fine powders using sample
grinders. Powdered samples were extracted with
phosphate-buffered saline (PBS) (137 mM NaCl, 1.4 mM
KH2PO4, 4.3 mM Na2HPO4, 2.7 mM KCl, pH 7.2). The
extracts were centrifuged at 15,000 g for 15 min, the
lipid layer was removed, and the supernatant was then
collected and lyophilized. The recovery amount of dried
TKE was approximately 20–25 mg/g samples.
Animal experiment and glucose tolerance tests
Five-week-old female BALB/c and male C57BL/6J mice
were obtained from National Laboratory Animal Center
(Taipei, Taiwan). Mice were maintained under a
12 h day-12 h night cycle and had free access to water
and food. Mouse experiments were conducted under
ethics approval from China Medical University Animal
Care and Use Committee (Permit No. 104-75-N).
To induce type 1 diabetes, C57BL/6J mice were
injected daily with 50 mg/kg STZ by an intraperitoneal
route for five consecutive days. Fourteen to 16 days after
final injection, fasting blood glucose levels were deter-
mined by a glucose oxidase method using a glucometer
(ACCU-CHEK Advantage, Roche Diagnostics, Basel,
Switzerland). To induce type 2 diabetes, C57BL/6J mice
were fed with high-fat diet (TestDiet, St. Louis, MO,
USA), in which 60% of energy was from fat. One week
later, mice were intraperitoneally given with 100 mg/kg
STZ and 240 mg/kg nicotinamide on days 0 and 2.
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Fasting blood glucose levels were determined on 30 days
after challenge [15]. Mice with fasting blood glucose
levels ≥230 mg/dL were selected and divided randomly.
Glucose tolerance test was performed as described previ-
ously [16, 17]. Briefly, mice were starved overnight and
TKE or TKP were then orally given 15 min before intra-
peritoneally injection of glucose solution (4 g/kg for
normal mice and 1 g/kg for diabetic mice). Blood sam-
ples were collected from tails at 0, 30, 60, 90, 120, 180,
or 240 min after glucose challenge. Glucose clearance
was evaluated by calculating the area under the curve
(AUC) of the glycemic profile.
2-DE and LC-MS/MS analysis of TKE
The protein composition of TKE was analyzed by 2-DE
and LC-MS/MS as described previously [16]. Briefly,
trichloroacetic acid-precipitated protein samples
(200 μg) were applied to IPG strips (7 cm, pH 3-10).
Isoelectric focusing was performed using a Protean IEF
Cell (Bio-Rad, Hercules, CA, USA) by the following
program: 0–250 V over 250 Vh, 250–4000 V over 4000
Vh, and 4000 Vh for 20,000 V. Focused IPG strips were
then separated by sodium dodecyl sulfate-polyacrylamide
gel (SDS-PAGE) on 15% acrylamide gels. Protein spots on
the gels were visualized by Coomassie Brilliant Blue R-250.
For LC-MS/MS analysis, protein spots were excised
from stained gels, in-gel digested by trypsin, and then
identified using an Ultimate capillary LC system (LC
Package, Amsterdam, The Netherlands) coupled to a
QSTARXL quadrupole-time-of-flight mass spectrometer
(Applied Biosystem/MDS Sciex, Foster City, CA, USA).
MS/MS data were matched against NCBI Inr and Swiss-
Prot using the MASCOT search program (http://www.ma-
trixscience.com/).
Homologous modeling and molecular docking
The structure of identified protein from TK was mod-
eled using trypsin inhibitor from Momordica charantia
(PDB code 1VBW) as a reference protein. PatchDock
was used for the prediction of interaction between iden-
tified protein and IR (PDB code 3LOH).
Cloning and purification of TK protein (TKP)
To clone the TKP cDNA, total RNA was extracted from
TK, reverse transcribed by SuperScript® III, and ampli-
fied with P1 (5′- GATCAAGCTTATGTGTCAGGGGA
AGTCGTCGTGGCCGCAG-3′) and M1 (5′-GATCGA
GCTCTCAACCGATGGTGGGGGGGCGGGCGACGA
T-3′) primers. The resulting 215-bp TKP cDNA
fragment was inserted into HindIII and SacI sites of
pBluescript II KS (-) vector to create pBKS-TKP. DNA
was sequenced on both strands of at least two repeats of
cloned DNA fragments. The protein sequence of TKP
has been deposited in GenBank (accession number:
KP677558). TKP was purified by gel filtration as
described previously [18]. The purity of TKP was ap-
proximately 95%, judged by SDS-PAGE.
IR kinase activity assay
The binding of TKP to IR was measured by IR kinase ac-
tivity assay. IR kinase activity assay was performed as de-
scribed previously [17, 18]. Briefly, mixtures containing
IR (Sigma, St. Louis, MO, USA) and various amounts of
insulin or TKP in kinase buffer (25 mM HEPES, pH 7.6,
25 mM MgCl2, 100 μM ATP, 100 μM sodium orthovana-
date, 2.5 mg/mL poly(Glu,Tyr), 25 μCi/mL [γ-32P]ATP)
were incubated at 30 °C for 10 min and spotted on chro-
matography papers. Poly(Glu,Tyr) was precipitated on
papers by soaking papers in 10% trichloroacetic acid solu-
tion, and the radioactivity incorporated into the
precipitated poly(Glu,Tyr) was counted by scintilla-
tion counter.
Statistical analysis
Continuous variables were presented as mean ± standard
error. Category variables were estimated the statistical
significance by one-way ANOVA and post hoc Bonfer-
roni test using SPSS Statistics version 20 (IBM, Armonk,
NY, USA). A p value less than 0.05 was considered as
statistical significance.
Results
Evidence-cased Chinese medicinal herbs commonly used
in diabetic patients in Taiwan
We conducted a retrospective cohort study to analyze
the Chinese medicinal herbs commonly used among
diabetic patients. The most frequently prescribed
Chinese medicinal herb was TK (5.71%), followed by
Astragalus mongholicus (4.76%), Salvia miltiorrhizae
(4.66%), Dioscoreae opposita (4.18%), Scrophularia
ningpoensis (2.78%), Ophiopogonis japonicus (2.68%),
Pueraria lobata (2.40%), Atractylodes lancea (1.74%),
Dendrobium nobile (1.73%), and Rehmannia glutinosa
(1.49%) (Table 1).
We further analyzed the disease pattern that TK
was frequently used for. By analyzing the LHID 2000,
we found that 70,093 patients (15.83%) with endo-
crine, nutritional and metabolic diseases, and immun-
ity disorders had treated with TK. By further
analyzing the frequency of TK used among various
endocrine disorders (ICD-9-CM, 250–259), we found
that diabetes mellitus (ICD-9-CM, 250), other endo-
crine disorders (ICD-9-CM, 259), and ovarian
dysfunction (ICD-9-CM, 256) were top three endo-
crine diseases that TK was used for. These findings
suggested that the most common disease that TK was
treated for was diabetes (Fig. 1). Moreover, TK was
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also the most frequently used Chinese medicinal herb
in diabetic patients in Taiwan.
TKE exhibited hypoglycemic effects with a biological
gradient in BALB/c mice
To analyze whether TK exhibited hypoglycemic effects,
we prepared aqueous extract of TK and performed
glucose tolerance assay in BALB/c mice. As shown in
Fig. 2, fasting blood glucose levels of mice were approxi-
mately 70 mg/dL, and the blood glucose concentration
reached a maximal level at 30 min after glucose chal-
lenge. Oral administration of TKE resulted in a more
rapid clearance of glucose than that observed in mock
group. Moreover, the hypoglycemic activity of TKE
displayed a dose-dependent manner, and the inhibition
reached 26.4 ± 3.19% at 2 g/kg. These data suggested
that TKE exhibited hypoglycemic abilities in mice.
Identification of protein constituents in TKE
Proteins are major components in the aqueous extract
of plants. 2-DE coupled with LC-MS/MS analysis was
therefore performed to evaluate the composition of
protein constituents in TKE. As shown in Fig. 3a, TKE
contained several low-molecular weight proteins and
there was a visible and abundant low-molecular weight
protein spot with an isoelectric point of 10 on the gels
of TKE. The content of this protein spot in TKE was
35.21% (Fig. 3a, red circle).
We further excised this protein spot from gels and
identified the protein by LC-MS/MS. By comparison
with green plants (Viridiplantae) taxonomy, we found
that there were no known proteins in database which
were matched to the amino acid sequences of this
protein spot in TKE. Therefore, we cloned and identified
a novel protein TKP from TK based on the LC-MS/MS-
defined amino acid sequences (Fig. 3b).
TKP activated IR kinase activities
Docking analysis was further performed to predict the
interaction between TKP and IR. As shown in Fig. 4a,
TKP directly docked into IR and fitted to the leucine-
rich region L1 and cystein-rich region CR of IR. IR is a
transmembrane protein that exhibits the tyrosine kinase
activity. Binding of insulin to IR stimulates the intrinsic
tyrosine kinase activity, leading to the autophosphoryl-
ation of IR. Therefore, we performed IR kinase activity
assay to analyze whether TKP interacted with IR and
activated IR kinase activities. As shown in Fig. 4b, the
radioactivities incorporated into the precipitated
poly(Glu,Tyr) were increased in the presence of TKP,
and the increase displayed a dose-dependent manner.
These data suggested that TKP was able to activate
IR kinase activities.
TKP stimulated the clearance of glucose in diabetic mice
To analyze whether TKP displayed hypoglycemic effects
in diabetic C57BL/6J mice, we orally administered mice
with various amounts of TKP. As shown in Fig. 5, the
fasting blood glucose levels of type 1 and type 2 diabetic
mice were approximately 500 mg/dL and 480 mg/dL,
Table 1 Top 10 Chinese medicinal herbs prescribed for type 2
diabetes patients in Taiwan
Chinese medicinal herbs (Chinese name) Na (%)
Trichosanthes kirilowii Maxim., root
(Tian Hua Fen)
42,013 (5.71)
Astragalus mongholicus Bunge, root
(Huang Qi)
35,025 (4.76)
Salvia miltiorrhizae Bge, root
(Dan Shen)
34,287 (4.66)
Dioscoreae opposita Thunb., root
(Shan Yiao)
30,769 (4.18)
Scrophularia ningpoensis Hemsl., root
(Xuan Shen)
20,421 (2.78)
Ophiopogon japonicus (Thunb.) Ker
Gawl., tuber (Mai Men Dong)
19,744 (2.68)
Pueraria lobata (Willd.) Ohwi, root
(Ge Gen)
17,641 (2.40)
Atractylodes lancea (Thunb.) DC., root
(Cang Zhu)
12,803 (1.74)
Dendrobium nobile Lindl., stem (Shi Hu) 12,749 (1.73)
Rehmannia glutinosa Libosch, root
(Di Huang)
10,948 (1.49)
aTotal prescription number is 141,103
Fig. 1 Analysis of the usage of TK in LHID 2000. Usage distributions (%) of TK in patients with endocrine disorders (ICD-9-CM codes 250–259)
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respectively. After glucose challenge, the levels of blood
glucose reached to 800 mg/dL at 1 h. TKP stimulated
the glucose clearance in both type 1 and type 2 diabetic
mice, compared with mock. Moreover, the stimulation
displayed a dose-dependent manner. These findings
suggested that TKP might be the potent ingredient re-
sponsible for the blood glucose-modulating ability of TK.
Discussion
TK has been widely used for treating cardiovascular,
cerebrovascular, and respiratory diseases due to the
clearance of heat, the dissipation of phlegm, the amelior-
ation of chest stuffiness, and the regulation of flow of
vital energy in TCM [10]. In combination with other
Chinese medicinal herbs, TK is also used for cancer
Fig. 2 Hypoglycemic effects of TKE in mice. BALB/c mice were orally administered PBS, various amounts of TKE. Fifteen minutes later, glucose solution
(4 g/kg) was administered intraperitoneally, blood samples were collected at the indicated time points, and blood glucose levels were measured by a
glucometer. AUC of glycemic profile is shown at the bottom. Data are expressed as mean ± standard error (n = 5). **p < 0.01, ***p < 0.001, compared
with mock
Fig. 3 2-DE and LC-MS/MS analysis of protein constituents in TKE. a 2-DE. TKE was separated on pH 3-10 strips, followed by SDS-PAGE on 15%
polyacrylamide gels. Proteins were visualized by Coomassie Brilliant Blue R-250. Protein size markers (in kDa) are shown on the left. Protein spot in
red circle was excised and analyzed by LC-MS/MS. Photos are representative images of three independent experiments. b TKP sequences obtained
by LC-MS/MS
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treatment [19]. Ni et al. (2015) reported that tricho-
santhes fruits inhibit non-small cell lung cancer cell
growth through cell-cell and mitosis arrest [20]. In
addition, triterpenoid-enriched extract of trichosanthes
roots display anti-inflammatory activities in experimen-
tal acute and chronic inflammation models in rats [21].
In combination with other herbs, TK also displays an
anti-arthritic efficacy in patients with osteoarthritis of
the knee and anti-allergic inflammation in murine
asthma model [22, 23]. TK is able to clear the heat,
promote the production of body fluids, and resolve the
swelling. Therefore, it has been traditionally prescribed
for patients with diabetes, coughing, breast abscess, in-
flammation, and cancer-related symptoms in TCM.
TK is a member of family Cucurbitaceae. Plants of
Cucurbitaceae family are cultivated throughout the
world for use as nutritious vegetables as well as medica-
tions. Extracts of some gourds, such as Momordica
charantia, Cucurbita maxima and Cucumis sativus, have
been commonly used for the treatment of diabetes and
related conditions among the indigenous populations of
Asia, South America, India, and East Africa [24–26].
Animal and human studies also indicate the hypoglycemic
effects of gourds. For example, extracts of Cucumis sativus
seeds are effective on diminishing blood glucose levels
and controlling the loss of body weight in STZ-induced
diabetic rats through a mechanism similar to euglycemic
agents [27]. Oral administration of pumpkin extract sig-
nificantly decreases blood glucose levels in STZ-induced
rats and diabetic patients via the increase of insulin secre-
tion, the increase of β-cell mass, or the inhibition of
α-amylase and α-glucosidase [28, 29]. In addition, extracts
of Momordica charantia reduce blood glucose levels in
diabetic rats and patients via the stimulation of transloca-
tion of glucose transporter 4, the promotion of β-cell
recovery, and the inhibition of protein-tyrosine phosphat-
ase 1B [30–32]. In this study, we found that TK was the
most frequently used Chinese medicinal herb in
Fig. 4 Interaction between TKP and IR. a Docking analysis. The IR ectodomain monomer is shown in a schematic presentation. Individual domains are
colored as follows: L1, blue; CR, pink; L2, green; fibronectin type III domain, orange. TKP is shown in an atomic sphere representation. b IR kinase activity
assay. Various amounts of TKP were incubated with IR in the presence of 32P-ATP and poly(Glu,Tyr). The radioactivity (dpm) incorporated into the
precipitated poly(Glu,Tyr) was counted by a scintillation counter
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diabetic patients in Taiwan. In addition, TKP displayed
hypoglycemic effects in mice. These findings suggested that
plants or herbs belonging to family Cucurbitaceae might
commonly exhibit blood glucose-modulating abilities.
Several constituents with various pharmacological
activities have been identified from TK. For example, tri-
chosanthin is a 27-kDa ribosome inactivating protein
that displays abortifacient, anti-viral, and immune-
regulatory functions [33]. It also exhibits anti-cancer
activities by the induction of apoptosis through G1
arrest, anti-telomerase effects, and anti-metastatic abil-
ities [34, 35]. A serine protease with 46.62 kDa in TK
fruits displays a potent anti-colorectal cancer activity by
inducing apoptosis via phosphatidylinositol 3′-kinase/
Akt-mediated mitochondria-dependent pathway [36].
Trichosans A, B, C, D, and E are glycans isolated from
the water extract of trichosanthes roots. These glycans
show hypoglycemic actions in normal mice, while trichosan
A also exhibits a hypoglycemic activity in alloxan-induced
hyperglycemic mice [12]. Saponins, flavonoids, triterpenes,
and proteins have been identified as hypoglycemic compo-
nents in gourds. For example, phenolic phytochemi-
cals and protein-bound polysaccharides from fruits of
Cucurbita maxima reduce blood glucose and improve
glucose tolerance via the inhibitions of α-amylase and
α-glucosidase [28, 29]. Bitter melon-derived triterpe-
noids activate AMP-activated protein kinase, increase
glucose transporter 4 translocation to the plasma mem-
brane in vitro, and improve glucose disposal in insulin-
resistant models in vivo [37]. Polypeptide-p, M.Cy protein,
MC6, and charantin from Momordica charantia show
hypoglycemic effects in normal and diabetic mice [31, 38,
39]. In addition, an IR-binding protein in Momordica
charantia binds to IR, triggers insulin signaling transduc-
tion, and stimulates the glucose clearance in vitro and in
vivo [17, 18]. In the present study, we newly identified a
novel TKP that exhibited hypoglycemic abilities in diabetic
mice. Because of the abundance of TKP in the extract of
Fig. 5 Hypoglycemic effects of TKP in diabetic mice. Type 1 (a) and type 2 (b) diabetic C57BL/6J mice were orally administered various amounts
of TKP. Blood glucose levels were measured after 1 g/kg glucose challenge. AUC of glycemic profile is shown at the right. Data are expressed as
mean ± standard error (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001, compared with mock
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TK, we speculated that TKP might be the potent
hypoglycemic protein responsible for the blood glucose-
modulating abilities of TK.
Conclusion
In conclusion, TK is traditionally used for the treatment
of diabetic patients in TCM. In this study, we found that
TK is the most common used herb in type 2 diabetic
patients in Taiwan. TKE exhibited hypoglycemic abilities
in mice. TKP in TK interacted with IR, stimulated IR
kinase activity, and enhanced the glucose clearance in
diabetic mice. This is the first report applying a bed-to-
bench approach to elucidate the hypoglycemic efficacies
of TK. Our findings might provide a reasonable explan-
ation of TK on the treatment of diabetes in TCM.
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